scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PNAS..10710696D |
P356 | DOI | 10.1073/PNAS.1004882107 |
P932 | PMC publication ID | 2890792 |
P698 | PubMed publication ID | 20498071 |
P5875 | ResearchGate publication ID | 44626117 |
P50 | author | David Hockenbery | Q110718522 |
Patrick Carroll | Q43183467 | ||
P2093 | author name string | Michael Lagunoff | |
Tracie Delgado | |||
Daciana Margineantu | |||
Almira S Punjabi | |||
P2860 | cites work | Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose | Q48017824 |
Effect of oxamate on glycolysis and respiration in sarcoma 37 ascites cells | Q72223285 | ||
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria | Q24595940 | ||
Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy | Q24646296 | ||
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 | Q24681460 | ||
Cancer cell metabolism: Warburg and beyond | Q28293198 | ||
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia | Q28300406 | ||
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption | Q28300415 | ||
Dynamics of the cellular metabolome during human cytomegalovirus infection | Q28469080 | ||
On respiratory impairment in cancer cells | Q29617276 | ||
Akt stimulates aerobic glycolysis in cancer cells | Q29619301 | ||
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements | Q33771214 | ||
Glycolysis during early infection of feline and human cells with feline leukemia virus. | Q34107557 | ||
Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells | Q34124015 | ||
Sirolimus for Kaposi's sarcoma in renal-transplant recipients | Q34556363 | ||
Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. | Q34768392 | ||
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis | Q35026060 | ||
Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors | Q35139228 | ||
Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. | Q35784707 | ||
Sugar and fat - that's where it's at: metabolic changes in tumors | Q36643052 | ||
Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells | Q36845797 | ||
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics | Q36862390 | ||
Mitochondria in cancer cells: what is so special about them? | Q37093125 | ||
Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. | Q37325401 | ||
De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells | Q39748116 | ||
Tumor metabolism: cancer cells give and take lactate | Q39912324 | ||
2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer | Q40021272 | ||
Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression | Q40173444 | ||
Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells | Q42141115 | ||
Hypersensitization of tumor cells to glycolytic inhibitors | Q43593851 | ||
Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus | Q45823721 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
Kaposi's sarcoma | Q725345 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 10696-10701 | |
P577 | publication date | 2010-05-24 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells | |
P478 | volume | 107 |
Q38754491 | (13) C-metabolic flux analysis of human adenovirus infection: Implications for viral vector production. |
Q40082053 | A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus |
Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
Q34100180 | A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells |
Q37102331 | A viral kinase mimics S6 kinase to enhance cell proliferation |
Q38073761 | AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV |
Q93081050 | Accelerated Metabolite Levels of Aerobic Glycolysis and the Pentose Phosphate Pathway Are Required for Efficient Replication of Infectious Spleen and Kidney Necrosis Virus in Chinese Perch Brain Cells |
Q38902275 | Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection |
Q36364238 | Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression |
Q34395302 | Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas |
Q36019773 | An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis |
Q28539677 | An invertebrate Warburg effect: a shrimp virus achieves successful replication by altering the host metabolome via the PI3K-Akt-mTOR pathway |
Q36177999 | Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway |
Q42425087 | Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma-Associated Herpesvirus-Infected Endothelium |
Q59351136 | Contemporary Ribonomics Methods for Viral microRNA Target Analysis |
Q34200085 | Correlation of brain amyloid with “aerobic glycolysis”: A question of assumptions? |
Q26749066 | DNA Tumor Viruses and Cell Metabolism |
Q35115662 | Dengue virus induces and requires glycolysis for optimal replication |
Q43140967 | Diabetes and risk of Kaposi's sarcoma: effects of high glucose on reactivation and infection of Kaposi's sarcoma-associated herpesvirus |
Q43145651 | Dr. Otto heinrich warburg-survivor of ethical storms |
Q64110424 | Dual Analysis of Virus-Host Interactions: The Case of 1 and the Cupped Oyster |
Q36122839 | Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma |
Q37057685 | Emmprin and KSHV: new partners in viral cancer pathogenesis. |
Q34228247 | Endothelial cell metabolism: parallels and divergences with cancer cell metabolism |
Q36021076 | Enolase-1 is a therapeutic target in endometrial carcinoma |
Q38722933 | Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways |
Q61800540 | Extracellular vesicles from Kaposi Sarcoma-associated herpesvirus lymphoma induce long-term endothelial cell reprogramming |
Q36167973 | Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. |
Q34390540 | Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection |
Q40301190 | Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication |
Q36171886 | Herpes Simplex Virus 1 Infection Activates Poly(ADP-Ribose) Polymerase and Triggers the Degradation of Poly(ADP-Ribose) Glycohydrolase |
Q38610039 | Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs |
Q64067571 | How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication |
Q90308027 | Human Herpesvirus 8 and Host-Cell Interaction: Long-Lasting Physiological Modifications, Inflammation and Related Chronic Diseases |
Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
Q42366342 | Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. |
Q89621489 | Identification of AIDS-Associated Kaposi Sarcoma: A Functional Genomics Approach |
Q37499665 | Identification of differentially expressed proteins in porcine alveolar macrophages infected with virulent/attenuated strains of porcine reproductive and respiratory syndrome virus |
Q34450834 | Imbalanced oxidative stress causes chlamydial persistence during non-productive human herpes virus co-infection |
Q58744915 | Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses |
Q36296882 | Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism. |
Q36318661 | KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma |
Q34644229 | Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation |
Q37418380 | Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line |
Q38114627 | Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)—an update |
Q35689577 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen and Angiogenin Interact with Common Host Proteins, Including Annexin A2, Which Is Essential for Survival of Latently Infected Cells |
Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
Q34257830 | Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells |
Q38800732 | Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment |
Q28546705 | Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival |
Q26860983 | Lipids at the interface of virus-host interactions |
Q37284264 | Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells. |
Q92327692 | Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas |
Q36719271 | Metabolic flux profiling of MDCK cells during growth and canine adenovirus vector production |
Q53781024 | Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia |
Q38674284 | Metabolic reprogramming: a hallmark of viral oncogenesis. |
Q34289122 | Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth. |
Q35846798 | Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. |
Q47547495 | Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies KSHV microRNA targets in endothelial cells |
Q37068487 | Modulation of B-cell exosome proteins by gamma herpesvirus infection |
Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
Q59351571 | More than just oncogenes: mechanisms of tumorigenesis by human viruses |
Q37870334 | Multifaceted roles for lipids in viral infection |
Q35607792 | Neutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis |
Q38568602 | Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma |
Q59350363 | Oncogenic KSHV Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, to Activate the STAT3 Pathway and Promote Growth Transformation |
Q35671327 | Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store |
Q90660427 | Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis |
Q58555606 | Oncogenic virus-induced aerobic glycolysis and tumorigenesis |
Q36238539 | RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. |
Q47551073 | RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism |
Q28828311 | Six Hours after Infection, the Metabolic Changes Induced by WSSV Neutralize the Host's Oxidative Stress Defenses |
Q28084730 | Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network |
Q36092308 | Suppressive Regulation of KSHV RTA with O-GlcNAcylation |
Q37604410 | Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism |
Q37595395 | TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection. |
Q91536702 | Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy |
Q34171822 | Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy |
Q36187455 | The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival |
Q33872257 | The MARCH Family E3 Ubiquitin Ligase K5 Alters Monocyte Metabolism and Proliferation through Receptor Tyrosine Kinase Modulation |
Q38626635 | The Role of Human Herpesvirus 8 in Diabetes Mellitus Type 2: State of the Art and a Medical Hypothesis |
Q47552056 | The Voltage-Dependent Anion Channel (VDAC) of Pacific Oysters Crassostrea gigas Is Upaccumulated During Infection by the Ostreid Herpesvirus-1 (OsHV-1): an Indicator of the Warburg Effect. |
Q58750618 | The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer |
Q63727598 | The inflamed sputum in lower respiratory tract infection: l -lactate levels are correlated to neutrophil accumulation |
Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
Q35138406 | The rate of oxygen utilization by cells |
Q38248404 | The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma |
Q39329214 | The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. |
Q38191881 | The wonders of 2-deoxy-D-glucose |
Q46272510 | Tools to Measure Cell Health and Cytotoxicity Using High Content Imaging and Analysis |
Q60956149 | Transcriptional and Small RNA Responses of the White Mold Fungus to Infection by a Virulence-Attenuating Hypovirus |
Q52727826 | Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1. |
Q37713842 | Vaccinia virus requires glutamine but not glucose for efficient replication |
Q47104746 | Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines. |
Q33911258 | Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. |
Q35619821 | Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis |
Q35582251 | Viral activation of cellular metabolism |
Q66679091 | Viral hijacking of cellular metabolism |
Q38049434 | Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy |
Q35599322 | White spot syndrome virus induces metabolic changes resembling the warburg effect in shrimp hemocytes in the early stage of infection |
Q40120040 | microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus. |
Search more.